Revvity/RVTY

$107.12

-2.25%
-
1D1W1MYTD1YMAX

About Revvity

Revvity, Inc. is a provider of products, services and solutions for the diagnostics and life sciences. The Company is focused on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more. Its Life Sciences segment provides products and services targeted towards the life sciences market. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. Its portfolio includes research and development (R&D), clinical and diagnostics, platforms and automation, signals software, and advanced services and licensing. It offers genomic analysis, protein analysis, cell analysis, and research solutions. It offers clinical and diagnostics in the field of reproductive health, infectious diseases, autoimmunity, endocrinology, allergy, cancer, neurodegeneration, and rapid patient testing.

Ticker

RVTY

Sector

Healthcare

Trading on

NYSE

Industry

Scientific & Technical Instr.

CEO

Prahlad Singh

Employees

11,500

Headquarters

Waltham, United States

Revvity Metrics

BasicAdvanced
$13.54B
Market cap
19.93
P/E ratio
$5.50
EPS
1.10
Beta
$0.28
Dividend rate
0.26%
Dividend yield

What the Analysts think about Revvity

Analyst Ratings

Majority rating from 19 analysts.
Buy

Price Targets

Average projection from 16 analysts.
17.44% upside
High $185.00
Low $108.00
$107.12
Current price
$125.80
Average price target

Revvity Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.28% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$695.9M
3.76%
Net income
$78.5M
735.11%
Profit margin
11.28%
705.71%

Revvity Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.42%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.01
$1.21
$1.18
$1.25
-
Expected
$1.06
$1.19
$1.19
$1.16
$0.93
Surprise
-5.05%
2.09%
-1.07%
7.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Revvity stock

Buy or sell Revvity stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing